Cortagen Peptide

$54.00

Description

Cortagen Peptide

Cortagen (also known as Cortexin or Cortexin-like peptide) is a synthetic tetrapeptide with the sequence Ala-Glu-Asp-Gly (AEDG). It’s part of a class of bioregulatory peptides developed in Russia, primarily researched for its neuroprotective and nootropic effects. Originally derived from cortical tissue extracts, it’s marketed as a research chemical or supplement in some regions, often in injectable or nasal spray forms. It’s not FDA-approved for human use in the US and is typically sold for “research purposes only.”

Purported Benefits and Mechanism

Cortagen is claimed to:

Support brain health: Enhances neuron repair, reduces oxidative stress, and improves synaptic plasticity.
Cognitive enhancement: May boost memory, learning, focus, and recovery from brain injuries (e.g., stroke, TBI).
Neuroprotection: Modulates gene expression in brain cells, increases neurotrophic factors like BDNF, and protects against ischemia or neurodegeneration.

Evidence:

Russian studies: Small clinical trials (e.g., 1990s-2000s) on Cortexin (a related extract) showed benefits for stroke recovery and cognitive decline. A 2005 study in Neuroscience and Behavioral Physiology reported improved memory in rats via hippocampal gene activation.
Peptide-specific research: Limited; a 2012 Russian paper in Bulletin of Experimental Biology and Medicine found Cortagen normalized brain metabolism in stressed rats, reducing lipid peroxidation.
Anecdotal: Biohacker communities (e.g., Reddit’s r/Peptides) report subtle cognitive boosts at low doses, but placebo-controlled human trials are scarce.
Limitations: Most data is from Russian sources with methodological issues (small n, no blinding). Western validation is minimal; it’s not listed in PubMed extensively.

Dosage and Administration (Research Contexts)

Form	Typical Dose	Frequency	Notes
Subcutaneous Injection	100-500 mcg/day	1-2x daily, 10-20 days	Most common; cycle off 1-2 months
Nasal Spray	200-400 mcg/spray (1-2 sprays)	1-3x daily	Less invasive, ~70% bioavailability
Oral	Not standard (poor absorption)	N/A	Avoided

Stacking: Often combined with Semax or Selank for synergy.
Half-life: Short (~hours), so split dosing.

Side Effects and Safety

Common: Mild injection site irritation, headaches (rare).
Rare: Allergic reactions; no major toxicity in animal studies up to 10x human doses.
Risks: Contamination in unregulated sources; unknown long-term effects. Contraindicated in pregnancy, epilepsy, or with psychotropics.
Legality: Research chemical in US/EU (not scheduled); prescription-only in Russia.

Sourcing and Recommendations

Buy from reputable vendors (e.g., Orovia BioLab, Peptide Sciences, CosmicNootropic) with third-party testing (HPLC/MS purity >98%). Avoid if under 18 or with medical conditions—consult a doctor. For deeper reading: Search PubMed for “Cortagen peptide” or Russian databases like eLibrary.ru.

Delivery Details

2-3 days from the time of purchase to all locations

Order now and enjoy great discounts! We deliver top-quality peptide products straight to you. Fast, reliable, and discreet service. Delivery hours: 10 AM–8 PM daily. Don’t miss out

Cortagen Peptide Research

Key Research Papers and Findings

Year	Study	Model	Key Findings	Source/Link
2002	Khavinson et al.	Rat brain cells	Normalized gene expression (e.g., MBP, GFAP); restored synaptic proteins post-stress. Dose: 10 mcg/kg.	Bulletin of Experimental Biology & Medicine PubMed: 12459834
2005	Ryzhak et al.	Rats (hypoxia model)	Improved memory retention (passive avoidance test); reduced brain lipid peroxidation by 30-40%.	Neuroscience & Behavioral Physiology eLibrary.ru
2012	Khavinson et al.	Aging rats	Upregulated 20+ brain genes (e.g., BDNF, NGF); enhanced hippocampal neurogenesis.	Bulletin of Experimental Biology & Medicine PubMed: 23058617
2014	Bondarenko et al.	Human stroke patients (n=40)	Cortexin (related) + rehab improved cognition (MMSE scores +15%) vs. rehab alone. Cortagen inferred similar.	Zhurnal Nevrologii i Psikhiatrii eLibrary.ru
2018	Khavinson review	Meta-analysis (animal/human)	Bioregulators like Cortagen activate ~2,000 genes; neuroprotective in ischemia/TBI models.	Advances in Gerontology PubMed: 30187848
2021	Kozina et al.	Cell culture (neurons)	Protected against glutamate excitotoxicity; boosted ATP production by 25%.	Biophysics Springer

Total PubMed hits: ~15 direct (search "Cortagen" OR "AEDG peptide"); 100+ on related Cortexin.
Clinical trials: 5+ small Russian trials (n=20-100); no Phase III. Registered on Russian Ministry of Health database.

Mechanisms of Action (Evidence-Based)

Epigenetic Regulation: Binds DNA, activating neuron-specific genes (e.g., via promoter demethylation). Confirmed via microarray in rat brains (Khavinson, 2012).
Antioxidant: Lowers ROS by 35% in hypoxic models; upregulates SOD/GSH-Px enzymes.
Neurotrophic: Increases BDNF/NGF mRNA by 1.5-2x; promotes synaptogenesis.
Anti-Inflammatory: Reduces TNF-α/IL-6 in microglia (in vitro, 2021).
Blood-Brain Barrier: High penetration (nasal > injection); peaks in hippocampus/cortex within 30 min.

Pathways: PI3K/Akt, MAPK/ERK (Western blot data from cell studies).

Evidence Quality and Gaps

Strength	Weakness
✅ Consistent animal data (n>500 across studies).<br>✅ Dose-response curves established.<br>✅ Low toxicity (LD50 >500 mg/kg).	❌ Small human trials, no RCTs.<br>❌ Publication bias (mostly Russian journals).<br>❌ No long-term safety data (>1 year).<br>❌ Limited pharmacokinetics in humans.

Effect Size: Moderate (Cohen's d ~0.6-0.8 for cognition in animals).
Comparisons: Similar to Semax but milder; outperforms Piracetam in Russian head-to-heads.

Ongoing/Recent Research

2023: Preprint on ResearchGate – Cortagen in Alzheimer's mouse model (APP/PS1); slowed plaque formation 20%.
Clinical analogs: Cortexin approved in Russia for TBI/stroke (200+ trials).
Western interest: Sparse; some nootropic studies reference it indirectly (e.g., via Limitless Biotech trials).